Primary liver cell carcinoma in the presence or absence of hepatitis b antigen
- 1 August 1976
- Vol. 38 (2) , 901-905
- https://doi.org/10.1002/1097-0142(197608)38:2<901::aid-cncr2820380237>3.0.co;2-d
Abstract
The clinical course and pathological patterns of a group of 13 patients with both primary liver cell carcinoma and Hepatitis B surface antigen (HBsAg) are described and contrasted with those of 43 patients with primary liver cell carcinoma but without HBsAg. HBsAg-positive carcinoma patients demonstrated a higher incidence of splenomegaly, transudative ascites, and the presence of alpha-fetoprotein, although none of these reached statistical significance. Serum bilirubin was significantly higher in patients with HBsAg. HBsAg-positive carcinoma patients most frequently originated from countries where the presence of HBsAg is high in the general population. Survival time from the diagnosis of primary liver cell carcinoma was shorter in patients with HBsAg.This publication has 17 references indexed in Scilit:
- Orcein staining of hepatitis B antigen in paraffin sections of liver biopsies.Journal of Clinical Pathology, 1975
- Primary Hepatoma and Hepatitis-associated Antigen in a Young White WomanBMJ, 1972
- HEPATITIS-ASSOCIATED ANTIGEN IN HEPATOMA IN SOUTH VIETNAMThe Lancet, 1972
- H.A.A. IN PRIMARY LIVER-CELL CARCINOMAThe Lancet, 1971
- AUSTRALIA ANTIGEN IN SINGAPORE CHINESE PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 1971
- HEPATITIS-ASSOCIATED ANTIGEN IN UGANDAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 1970
- CHRONIC LIVER DISEASE AND PRIMARY LIVER-CELL CANCER WITH HEPATITIS-ASSOCIATED (AUSTRALIA) ANTIGEN IN SERUMThe Lancet, 1970
- SERUM α1-FETOPROTEIN IN PATIENTS WITH LIVER DISEASEThe Lancet, 1969
- VIRAL HEPATITIS, POSTNECROTIC CIRRHOSIS, AND HEPATOCELLULAR CARCINOMAThe Lancet, 1969
- HEPATITIS-ASSOCIATED ANTIGEN IN CHRONIC LIVER DISEASEThe Lancet, 1969